Pharmaceuticals

  • Battle over price control: 50 drugs brought under price control sparks outrage July 19, 2014

    The government's decision to expand the number of drugs under price control has sparked a nation-wide debate. While health industry experts have called the move unwarranted and arbitrary, many believe that there is nothing new in the current decision as a lot of drugs were already under the purview of...
  • Government defends move to cap condom prices March 25, 2014

    New Delhi: The central government on Tuesday defended its decision to bring condoms under the Drug Price Control Order (DPCO), which has put a cap on prices of all male contraceptives in the country. Delhi High Court's acting Chief Justice BD Ahmed and Justice Sidharth Mridul was also informed by the...
  • Ranbaxy suspends drug ingredients shipment from 2 plants February 25, 2014

    Tokyo: Drugmaker Ranbaxy Laboratories Ltd on Tuesday said it has suspended all shipments of pharmaceutical ingredients produced at two local factories to review processes and controls. The Toansa and Dewas plants are currently banned from shipping products to the United States following quality concerns, so the suspension will hit supplies to...
  • Major pharmaceutical firm under scrutiny for producing spurious drugs October 17, 2013

    Ambala: Fake drugs are one of India's worst kept secrets. Almost 45 per cent of drugs distributed in the country are manufactured in Himachal Pradesh and a major company based in the state, Vardhaman Pharmaceuticals, is under scrutiny for producing and distributing spurious drugs across the country. Filthy machines prepare spurious...
  • Vardhman Pharmaceuticals under scanner for producing spurious drugs October 16, 2013

    Shimla: Vardhaman Pharmaceuticals, a private company in Himachal Pradesh, is under scanner for producing spurious drugs. CNN-IBN has accessed details showing how the company is producing spurious drugs. The licence of Vardhaman Pharmaceuticals lapsed in 2009. The company manufactured fake drugs and labelled them with the government supply stickers. These fake...
  • No clinical trial of untested drugs in absence of mechanism: Supreme Court September 30, 2013

    No clinical trials should be allowed for new drugs till a mechanism is put in place to monitor them and to protect the lives of people on which drugs are tested, the Supreme Court on Monday said. A bench headed by Justice RM Lodha said that a system must be put...
  • Government will soon finalise FDI policy on pharma sector: Chidambaram August 13, 2013

    Finance Minister P Chidambaram on Monday said the government will soon finalise the foreign investment policy on brownfield pharmaceutical projects, paving the way for clearance of held-up proposals. "...I believe the discussion (with regard to FDI in brownfield pharmaceuticals) between the Ministry of Commerce and Prime Minister and others is...
  • SC to hear PIL on the pricing of drugs in India August 5, 2013

    New Delhi: The Supreme Court on Monday will hear a PIL by the pharma companies on the pricing of medicines in India. The PIL was filed by four pharma firms who challenged the Delhi High Court's order to reduce the prices of certain medicines. These pharma companies were also asked to...
  • Clinical trial of untested drugs must be regulated: SC July 26, 2013

    New Delhi: Clinical trials of untested drugs on humans require certain mandatory standards to be followed, the Supreme Court said on Friday while directing the government to put in place a mechanism to monitor them. The apex court directed the Centre to convene a meeting of Chief Secretaries or Health Secretaries...
  • 9 pharmaceutical companies fined Rs 2500 cr for overcharging July 20, 2013

    New Delhi: Nine pharmaceutical companies have been fined Rs 2500 crore by the National Pharmaceutical Pricing Authority (NPPA) for overcharging customers. The NPPA imposed penalty after the drug makers, which also include Ranbaxy, Dr. Reddy's Lab, Glenmark, Cipla and Cadilla, were overcharging patients on Doxofylline. The asthma drug was being...
  • India ready to discuss patent policies with US lawmakers June 26, 2013

    Washington: Asserting that the Indian Patents Act related to pharmaceutical products is not discriminatory against foreign companies, Indian Ambassador to the United States, Nirupama Rao, offered concerned lawmakers to discuss the issue for the sake of long-term bilateral and strategic partnership between the two countries. "My senior colleagues at the...
  • A company can't depend on one person: Dr Reddy's Labs' GV Prasad June 17, 2013

    New Delhi: When I came back to India after graduation in the US, I knew I wanted to start a business but what that would be I didn't know. I joined the family business for a while and then set up a bulk drugs company, Benzex Labs, with my parents'...
  • US businesses complain about India trade practices June 6, 2013

    Washington: Leading US business groups on Wednesday urged President Barack Obama to act against what they said were "unacceptable" Indian trade practices that have hurt US exports in areas ranging from pharmaceuticals to electronics. The National Association of Manufacturers and other business groups expressed their concerns in a letter that was...
  • EU to fine Ranbaxy, others for blocking generic drugs June 4, 2013

    Brussels: A European regulator will fine Denmark's Lundbeck, India's Ranbaxy and seven other makers of generic drugs for limiting the supply of cheaper medicines, two people with knowledge of the matter said, its first sanction against "pay-for-delay" deals. Following an inquiry launched in 2009, the European Union's anti-trust regulator will impose...
  • Patent row: Delhi HC to hear diabetes drug case May 23, 2013

    New Delhi: The patent battle between US pharmaceuticals major Merck Sharp and Dohme (MSD) and Indian firm Glenmark Pharmaceuticals over the sale of diabetes drug Januvia comes up for hearing in the Delhi High Court on Thursday. Indian pharma company Glenmark recently came out with generic versions of Merck's type-2...
  • Drug prices to be slashed as pricing policy comes into effect May 17, 2013

    From July, more than 300 essential medicines will cost 20 to 25 per cent less, as the new national pricing policy comes into effect. How will this affect us and why are some calling it an eyewash? ...
  • Ranbaxy fined $ 500 mn for selling adulterated drugs May 14, 2013

    New Delhi: Generic drugmaker Ranbaxy has been fined $500 million by the US government after its subsidiary pleaded guilty to sale of adulterated drugs manufactured in India. It is the largest settlement by a generic medicine maker till date. It includes $150 million in payments for a criminal fine and...
  • Railway Board bribery case: Decoding the Bansal empire May 7, 2013

    Pawan Kumar Bansal is under fire over bribery charges against his nephew Vijay Singhla, who is also one of the directors of Jagan Realtors Private Limited, which has several other relatives of Bansal on board. ...
  • Railway scam: BJP trains guns on Bansal family's pharmaceutical company May 7, 2013

    The BJP has now claimed Theon Pharmaceuticals was involved in price fixing. Pawan Kumar Bansal's wife Madhu Bansal, sons Manish Bansal and Amit Bansal are directors in Theon Pharmaceuticals. ...
  • US: NY lawsuit accuses Novartis of healthcare fraud April 24, 2013

    New York: The US government has sued Novartis Pharmaceuticals Corp, claiming it gave kickbacks to pharmacies to switch kidney transplant patients from competitors' drugs to its own. The civil health care fraud lawsuit in US District Court in Manhattan seeks unspecified damages and civil penalties for a scheme that the...
  • Patent row: HC refuses interim relief to Merck April 5, 2013

    New Delhi: The Delhi High Court on Friday refused to grant interim relief on a patent row to US pharmaceuticals major Merck Sharp and Dohme (MSD) which sought a restraint on Indian firm Glenmark Pharmaceuticals manufacturing and marketing anti-diabetes drugs Zita and Zita-Met. Justice Rajiv Sahai Endlaw dismissed the interim...
  • Novartis cannot ignore India's huge market: Indian Pharmaceutical Alliance April 1, 2013

    The secretary general of the Indian Pharmaceutical Alliance, DG Shah said that Novartis was merely posturing and it could not ignore the huge market that India provided to its products. ...
  • Investments in India by global pharma cos to continue: Vikas Dandekar April 1, 2013

    In a landmark verdict, the Supreme Court dismissed a plea by the Swiss pharmaceutical giant Novartis on Monday for a patent on its cancer drug Glivec, paving the way for more affordable life-saving cancer drugs. How does it affect the Indian pharmaceutical industry and the global biggies who are looking...
  • SC to decide pharma patent, take up marines case April 1, 2013

    New Delhi: The Supreme Court will pronounce an important judgment on Monday on a Swiss pharma firm's plea asserting its patent over a medicine, and Tuesday take up Sterlite's plea opposing the order to shut down its plant as well as the case of the Italian marines. In a judgment that...
  • Dhoni named brand ambassador of Emcure Pharmaceuticals March 12, 2013

    New Delhi: Indian cricket captain, Mahendra Singh Dhoni, has been signed as the brand ambassador of Emcure Pharmaceuticals, a company that specialises in tablets, capsules, injectables and Onco products. The company has its presence in across Asia, Africa, CIS, Europe, Latin America and Middle East. The 31-year-old Dhoni, who has been...
  • Ranbaxy to sell generic anti-depression drug in US March 6, 2013

    Washington: The US arm of Indian drug major Ranbaxy Laboratories has entered into an in-licensing agreement with Alembic Pharmaceuticals Limited to exclusively market the generic version of Pfizer Inc.'s anti-depression drug Pristiq in the US. Jacksonville, Florida, base Ranbaxy Pharmaceuticals Inc (RPI) announced on Tuesday that Alembic manufactured Desvenlafaxine is a...
  • AP: Himalaya helps build jail inmates' herb farming skills February 19, 2013

    Ananthapur: Prisoners in Ananthapur in Andhra Pradesh are getting a second chance in life. Through a unique rehabilitation program started by the pharmaceutical company Himalaya, the inmates are now turning to herb farming. Shiva Shankar Reddy, a prisoner, has to supervise the tilling of the land so that the new...
  • Slow approvals put India's drug trials industry at risk February 13, 2013

    Mumbai/New Delhi: Slower government approval for testing new medicines is threatening India's aspirations to be a fast-growing, low-cost hub for clinical trials, and has prompted some drugs firms to shift operations elsewhere, adding to their costs. While India's drug regulator and the health ministry's medical research body deny any slowdown, interviews...
  • US exports may drive growth of Indian pharma companies February 3, 2013

    Mumbai: Top Indian pharma players will continue to grow strongly at over 20 per cent in 2013, primarily led by exports to the US market, India Ratings said in its outlook for the sector. "We believe that top players of the sector will continue to grow strongly in 2013 (over...
  • Yusuf Hamied declared Indian of the Year 2012 in business category December 12, 2012

    New Delhi: Yusuf Hamied, chairman of Indian pharmaceutical giant Cipla, has won the Indian of the Year 2012 award in the business category. Hamied, who is a leading Indian scientist, created a stir in pharmaceuticals industry when he slashed the prices of three important cancer drugs by 75 per cent. Hamied...